GB875007A - Hydrazinium salts - Google Patents

Hydrazinium salts

Info

Publication number
GB875007A
GB875007A GB904759A GB904759A GB875007A GB 875007 A GB875007 A GB 875007A GB 904759 A GB904759 A GB 904759A GB 904759 A GB904759 A GB 904759A GB 875007 A GB875007 A GB 875007A
Authority
GB
United Kingdom
Prior art keywords
amino
group
substituted
groups
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB904759A
Inventor
Bernard Rudner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WR Grace and Co
Original Assignee
WR Grace and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WR Grace and Co filed Critical WR Grace and Co
Priority to GB904759A priority Critical patent/GB875007A/en
Publication of GB875007A publication Critical patent/GB875007A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention comprises compounds of the formula <FORM:0875007/IV (b)/1> (wherein Ar is benzene, pyridine, naphthalene or quinoline; X and Y are affixed to the same ring of Ar and represent hydrogen or chlorine atoms or cyclohexoxy, hydroxy, lower alkoxy, amino, phenyl or lower alkylamino groups; Z is an oxygen atom or an NH group; B is a -CnH2n-, -CnH(2n-1) OH- or -CnH(2n-1) NRR1-group; R is an Ar-CO-Z-CnH2n-group or a lower alkyl radical which may be substituted by one or more OH groups and R1 is a lower alkyl radical which may be substituted by one or more OH groups, or R and R1, together with the adjacent nitrogen atom, form a morpholine, piperidine or pyrrolidine ring which may be substituted by a methyl group; n is an integer from 2 to 6; A is an anion; and the lower alkyl and lower alkoxy groups contain from 1 to 4 carbon atoms) and their preparation, where for example B is a -CnH2ngroup, either by reacting an amino-alcohol or diamine of the formula HZCnH2nNRR1 with chloramine and reacting the product of the formula [HZCnH2nNRR1 NH2]+Clwith the appropriate aryl acid chloride or by reacting chloramine with the appropriate amino-ester or amino-amide, with subsequent replacement, if desired, of the chloride ion in the products by another anion A- by reaction with the compound MA, where M is hydrogen or a metal. Examples are given and an extensive list of anions is provided. These include anions derived from mineral and other inorganic acids, common mono-basic and di-basic organic acids, choline, cation exchange resins, penicillins, aureomycin, tetracycline, amphomycin, sulphanilamide and other sulphonamides, barbiturates, folic acid, cinchophen and 8-hydroxyquinoline. A further list of suitable amino-ester and amino-amide starting materials is also provided. N-(3-morpholinopropyl)-p-anisamide is prepared from 4-(3-aminopropyl)-morpholine and p - anisoyl chloride. U.S.A. Specifications 2,220,929 and 2,710,248 are referred to.ALSO:Pharmaceutical compositions contain, as essential active ingredients, compounds of the formula <FORM:0875007/VI/1> (wherein Ar is benzene, pyridine, naphthalene or quinoline; X and Y are affixed to the same ring of Ar and represent hydrogen or chlorine atoms or cyclohexoxy, hydroxy, lower alkoxy, amino, phenyl or lower alkylamino groups; Z is an oxygen atom or an NH group; B is a -CnH2n-, -CnH(2n - 1)OH- or -CnH(2n - 1) NRR1- group; R is an Ar-CO-Z-CnH2n-group or a lower alkyl radical which may be substituted by one or more OH groups and R1 is a lower alkyl radical which may be substituted by one or more OH groups, or R and R1, together with the adjacent nitrogen atom, form a morpholine, piperidine or pyrrolidine ring which may be substituted by a methyl group; n is an integer from 2 to 6; A is an anion, and the lower alkyl and lower alkoxy groups contain from 1 to 4 carbon atoms. An aqueous solution of 1,1-dimethyl - 1 - (2 - benzoyloxy - 2 - methyl) butylhydrazinium chloride is described. U.S.A. Specifications 2,220,929 and 2,710,248 are referred to.
GB904759A 1959-03-16 1959-03-16 Hydrazinium salts Expired GB875007A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB904759A GB875007A (en) 1959-03-16 1959-03-16 Hydrazinium salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB904759A GB875007A (en) 1959-03-16 1959-03-16 Hydrazinium salts

Publications (1)

Publication Number Publication Date
GB875007A true GB875007A (en) 1961-08-16

Family

ID=9864372

Family Applications (1)

Application Number Title Priority Date Filing Date
GB904759A Expired GB875007A (en) 1959-03-16 1959-03-16 Hydrazinium salts

Country Status (1)

Country Link
GB (1) GB875007A (en)

Similar Documents

Publication Publication Date Title
GB1047935A (en) Substituted piperazines and preparation thereof
ES482134A1 (en) 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts thereof, processes for their preparation, and pharmaceutical compositions containing such compounds.
ES483767A1 (en) Alpha-(N-arylsulfonyl-L-argininamides, processes for their preparation and pharmaceutical compositions containing these substances.
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
GB1046506A (en) Guanidine compounds and process for their manufacture
GB1120463A (en) Derivatives of 1,3-diazafluoranthene-1-oxide
GB1142066A (en) New diphenyl-ureas and process for preparing them
GB875007A (en) Hydrazinium salts
ES424436A1 (en) 1-(Imidazole-1-yl)-isoquinolines and process for preparing them
ES8503347A1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them.
GB1353508A (en) Aminoisoquinolines
US2561948A (en) Aminoalkylated diamino diphenyl sulfones
GB1512101A (en) Piperazinopyrimidines process for their preparation and use
ES357317A1 (en) N-disubstituted 3-amino-1,2-benzisothiazoles as antimycotic agents
GB1058521A (en) New amino azacycloheptanones and process for their production
IL43365A (en) S-(n,n-disubstituted-(n&#39;,n&#39;-disubstituted sulfamoyl)-acetamidine)-esters of thiolphosphoric and thiolphosphonic acid and their thionothiol analogues and pesticidal compositions containing them
ES8704907A1 (en) Process for the preparation of derivatives of 4H-1,2,4-triazole, triazoles so obtained, their use as medicaments, and pharmaceutical compositons containing them.
GB1144516A (en) Novel oximes and a process for the manufacture and conversion thereof
GB1424147A (en) Agents for regulating plant growth
GB883220A (en) Improvements in or relating to morpholine derivatives
GB880334A (en) New hydrazinium compounds, their production and pharmaceutical compositions containing them
GB904706A (en) Isourea derivatives
ES8200661A1 (en) Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing them.
GB883741A (en) New hydrazinium salts, their production and pharmaceutical compositions containing them
GB822055A (en) Improvements in or relating to new analgesically active substituted alpha, alpha-diphenyl--y-amino-butyramides and the manufacture thereof